Technology WantedLooking for new technology - Biomarkers HDL Function
We are keenly aware of and continuously review discoveries and developments across the entire drug discovery and development community. To achieve this, our Review and Licensing Committees, each target a specific therapeutic area or technology. This means that we provide a formal review and response for every viable opportunity.
Areas of Interest:
- Platforms for measuring HDL-medicated reverse cholesterol transport, preclinically and clinically, including imaging and kinetic models.
- Platforms for determining protein or lipid composition of HDL.
Not Interested in:
- In vitro reverse cholesterol transport assays.